Furthermore, subgroup analysis showed a substantial impact of DAP3 on the prognosis of breast cancer subtypes, except for basal cell-like subtypes, estrogen receptor-negative subtypes, and human epidermal growth factor receptor-2 overexpression subtypes (P < 0.05). Here, DAP3 is linked to breast cancer.